Brimonidine Tartrate and Timolol maleate Ophthalmic Solution

Product NDC
68083-664
11-digit product format
680830664
Labeler code
68083
Product ID
68083-664_8c333ddc-18f1-4afc-8a70-1641c4f21ceb
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Brimonidine Tartrate and Timolol maleate
Dosage form
SOLUTION/ DROPS
Route
OPHTHALMIC
Labeler
Gland Pharma Limited
Application
ANDA219166
Marketing category
ANDA
Marketing start
2026-06-11
Substance
BRIMONIDINE TARTRATE; TIMOLOL MALEATE
Active strength
2; 5 mg/mL; mg/mL
Pharmacologic classes
Adrenergic alpha-Agonists [MoA], Adrenergic beta-Antagonists [MoA], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Blocker [EPC]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A219166-001BRIMONIDINE TARTRATE AND TIMOLOL MALEATEBRIMONIDINE TARTRATE; TIMOLOL MALEATE0.2%;EQ 0.5% BASESOLUTION/DROPS / OPHTHALMICAB2026-06-11

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
A219166-001AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08A219166-001BRIMONIDINE TARTRATE AND TIMOLOL MALEATE0.2%;EQ 0.5% BASESOLUTION/DROPS / OPHTHALMICAB2026-06-1184e616aacf4f…
2026-08-18 06:07:402026-07A219166-001BRIMONIDINE TARTRATE AND TIMOLOL MALEATE0.2%;EQ 0.5% BASESOLUTION/DROPS / OPHTHALMICAB2026-06-11caaa826d4ba7…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A219166-001BRIMONIDINE TARTRATE AND TIMOLOL MALEATE0.2%;EQ 0.5% BASESOLUTION/DROPS / OPHTHALMICAB2026-06-11a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-09-14 22:38:342026-08A219166-001AB184e616aacf4f…
2026-08-18 06:07:402026-07A219166-001AB1caaa826d4ba7…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A219166-001AB1a50c72e98297…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
Brimonidine Tartrate and Timolol maleate Ophthalmic Solution
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
BRIMONIDINE TARTRATE2 mg/mL
TIMOLOL MALEATE5 mg/mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
4S9CL2DY2HInternal UNII lookup
P8Y54F701RInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
861635Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
038cf2ba-ad08-4981-a3cc-bff0e4ba5dfbAvailable on FDA.report

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Brimonidine Tartrate and Timolol maleate Ophthalmic SolutionBRIMONIDINE TARTRATE AND TIMOLOL MALEATEGland Pharma Limited038cf2ba-ad08-4981-a3cc-bff0e4ba5dfb2026-06-16Warnings, Adverse reactionsExact identifier
application applno (ANDA): 219166
application number: ANDA219166
ndc (product): 68083-664

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
68083-664-01680830664011 BOTTLE, DROPPER in 1 CARTON (68083-664-01) / 15 mL in 1 BOTTLE, DROPPER2026-06-11NoNoCurrent